The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance

OBJECTIVE—We identified lipocalin 2 (Lcn2) as a gene induced by dexamethasone and tumor necrosis factor-α in cultured adipocytes. The purpose of this study was to determine how expression of Lcn2 is regulated in fat cells and to ascertain whether Lcn2 could be involved in metabolic dysregulation associated with obesity. RESEARCH DESIGN AND METHODS—We examined Lcn2 expression in murine tissues and in 3T3-L1 adipocytes in the presence and absence of various stimuli. We used quantitative Western blotting to observe Lcn2 serum levels in lean and obese mouse models. To assess effects on insulin action, we used retroviral delivery of short hairpin RNA to reduce Lcn2 levels in 3T3-L1 adipocytes. RESULTS—Lcn2 is highly expressed by fat cells in vivo and in vitro. Expression of Lcn2 is elevated by agents that promote insulin resistance and is reduced by thiazolidinediones. The expression of Lcn2 is induced during 3T3-L1 adipogenesis in a CCAAT/enhancer-binding protein–dependent manner. Lcn2 serum levels are elevated in multiple rodent models of obesity, and forced reduction of Lcn2 in 3T3-L1 adipocytes improves insulin action. Exogenous Lcn2 promotes insulin resistance in cultured hepatocytes. CONCLUSIONS—Lcn2 is an adipokine with potential importance in insulin resistance associated with obesity.

[1]  Masato Kasuga,et al.  [Obesity and insulin resistance]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[2]  E. Kraegen,et al.  Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. , 2007, Clinical chemistry.

[3]  Bruce M. Spiegelman,et al.  Adipocytes as regulators of energy balance and glucose homeostasis , 2006, Nature.

[4]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[5]  O. MacDougald,et al.  Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.

[6]  J. Manson,et al.  Iron Intake and the Risk of Type 2 Diabetes in Women , 2006, Diabetes Care.

[7]  E. Lander,et al.  Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.

[8]  B. Hemmings,et al.  PKBα is required for adipose differentiation of mouse embryonic fibroblasts , 2006, Journal of Cell Science.

[9]  T. Mak,et al.  Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Hemmings,et al.  PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. , 2006, Journal of cell science.

[11]  Michael R. Green,et al.  A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.

[12]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[13]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[14]  Ian R. Drexler,et al.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. , 2005, The Journal of clinical investigation.

[15]  P. Iyengar,et al.  The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.

[16]  Shizuo Akira,et al.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.

[17]  A. Green,et al.  Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. , 2004, Diabetes.

[18]  A. Friedl,et al.  Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression , 1999, The Histochemical Journal.

[19]  L. Tilbrook.  Cross talk between iron metabolism and diabetes. , 2004, Annals of clinical biochemistry.

[20]  H. Erdjument-Bromage,et al.  An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.

[21]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[22]  M. Nilsen-Hamilton,et al.  High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. , 2002, The Biochemical journal.

[23]  K. Kristiansen,et al.  A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes* , 2002, Molecular & Cellular Proteomics.

[24]  B. Spiegelman,et al.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. , 2002, Genes & development.

[25]  N. Barzilai,et al.  Hyperglycemia-induced Production of Acute Phase Reactants in Adipose Tissue* , 2001, The Journal of Biological Chemistry.

[26]  J. G. Teodoro,et al.  Induction of Apoptosis by a Secreted Lipocalin That is Transcriptionally Regulated by IL-3 Deprivation , 2001, Science.

[27]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[28]  N. Socci,et al.  Leptin-specific patterns of gene expression in white adipose tissue. , 2000, Genes & development.

[29]  J. Cowland,et al.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.

[30]  D R Flower,et al.  The lipocalin protein family: structure and function. , 1996, The Biochemical journal.

[31]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[32]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.